Literature DB >> 3652453

Alanine glyoxylate aminotransferase and the urinary excretion of oxalate and glycollate in hyperoxaluria type I and the Zellweger syndrome.

R J Wanders1, C W van Roermund, R Westra, R B Schutgens, M A van der Ende, J M Tager, L A Monnens, H Baadenhuysen, L Govaerts, H Przyrembel.   

Abstract

We have studied the urinary excretion of oxalate and glycollate in patients with the Zellweger syndrome and hyperoxaluria type I and have measured the activity of alanine glyoxylate aminotransferase (a peroxisomal enzyme in man) in the patients. In agreement with earlier reports we found that alanine glyoxylate aminotransferase was strongly deficient in liver from a hyperoxaluria type I patient, thus explaining the increased urinary excretion of oxalate and glycollate in these patients. In livers from Zellweger patients, however, in which morphologically distinguishable peroxisomes are absent, the enzyme was not deficient, which is in accordance with our finding that the urinary excretion of oxalate and glycollate was normal in these patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3652453     DOI: 10.1016/0009-8981(87)90176-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  Phytanic acid alpha-oxidation in man: identification of 2-hydroxyphytanoyl-CoA lyase, a peroxisomal enzyme with normal activity in Zellweger syndrome.

Authors:  G A Jansen; S Denis; N M Verhoeven; C Jakobs; R J Wanders
Journal:  J Inherit Metab Dis       Date:  2000-06       Impact factor: 4.982

Review 2.  Recent advances in the understanding, diagnosis and treatment of primary hyperoxaluria type 1.

Authors:  C J Danpure
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

Review 3.  Prenatal and perinatal diagnosis of peroxisomal disorders.

Authors:  R B Schutgens; G Schrakamp; R J Wanders; H S Heymans; J M Tager; H van den Bosch
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

4.  Diversity in residual alanine glyoxylate aminotransferase activity in hyperoxaluria type I: correlation with pyridoxine responsiveness.

Authors:  R J Wanders; C W van Roermund; S Jurriaans; R B Schutgens; J M Tager; H van den Bosch; E D Wolff; H Przyrembel; R Berger; F G Schaaphok
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

5.  Rapid identification of primary hyperoxaluria type I patients using a novel, fully automated method for measurement of hepatic alanine: glyoxylate aminotransferase.

Authors:  V A Horváth; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

6.  Post-mortem visualization of peroxisomes in rat and in human liver.

Authors:  D De Craemer; M Espeel; M Langendries; R B Schutgens; T Hashimoto; F Roels
Journal:  Histochem J       Date:  1990-01

Review 7.  In situ heterogeneity of peroxisomal oxidase activities: an update.

Authors:  R J Van den Munckhof
Journal:  Histochem J       Date:  1996-06

8.  Cytosolic compartmentalization of hepatic alanine:glyoxylate aminotransferase in patients with aberrant peroxisomal biogenesis and its effect on oxalate metabolism.

Authors:  C J Danpure; P Fryer; S Griffiths; K M Guttridge; P R Jennings; J Allsop; A B Moser; S Naidu; H W Moser; M MacCollin
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.